Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects
This study has been completed.
Study NCT01162122   Information provided by Novartis

First Received on July 13, 2010.   Last Updated on December 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza
Additional conditions recognized in this trial
Influenza, Human
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Additional drug interventions recognized in this trial
Formaldehyde
More general drug interventions related to this trial
Anti-Infective Agents
Disinfectants
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Novartis
Novartis Vaccines


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services